|
1
|
Surks MI, Ortiz E, Daniels GH, et al:
Subclinical thyroid disease: scientific review and guidelines for
diagnosis and management. JAMA. 291:228–238. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cooper DS and Biondi B: Subclinical
thyroid disease. Lancet. 379:1142–1154. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boelaert K: Thyroid dysfunction in the
elderly. Nat Rev Endocrinol. 9:194–204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hak AE, Pols HA, Visser TJ, Drexhage HA,
Hofman A and Witteman JC: Subclinical hypothyroidism is an
independent risk factor for atherosclerosis and myocardial
infarction in elderly women: the Rotterdam study. Ann Intern Med.
132:270–278. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rodondi N, Newman AB, Vittinghoff E, et
al: Subclinical hypothyroidism and the risk of heart failure, other
cardiovascular events, and death. Arch Intern Med. 165:2460–2466.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Walsh JP, Bremner AP, Bulsara MK, et al:
Subclinical thyroid dysfunction as a risk factor for cardiovascular
disease. Arch Intern Med. 165:2467–2472. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Razvi S, Weaver JU, Vanderpump MP and
Pearce SH: The incidence of ischemic heart disease and mortality in
people with subclinical hypothyroidism: reanalysis of the Whickham
Survey cohort. J Clin Endocrinol Metab. 95:1734–1740. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rodondi N, den Elzen WP, Bauer DC, et al:
Subclinical hypothyroidism and the risk of coronary heart disease
and mortality. JAMA. 304:1365–1374. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tseng FY, Lin WY, Lin CC, et al:
Subclinical hypothyroidism is associated with increased risk for
all-cause and cardiovascular mortality in adults. J Am Coll
Cardiol. 60:730–737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gencer B, Collet TH, Virgini V, Auer R and
Rodondi N: Subclinical thyroid dysfunction and cardiovascular
outcomes among prospective cohort studies. Endocr Metab Immune
Disord Drug Targets. 13:4–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Galkina E and Ley K: Immune and
inflammatory mechanisms of atherosclerosis. Ann Rev Immunol.
27:1652009. View Article : Google Scholar
|
|
13
|
Libby P, Ridker PM and Hansson GK:
Progress and challenges in translating the biology of
atherosclerosis. Nature. 473:317–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bonetti PO, Lerman LO and Lerman A:
Endothelial dysfunction: a marker of atherosclerotic risk.
Arterioscler Thromb Vasc Biol. 23:168–175. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Makino A and Kamata K: Possible modulation
by endothelin-1, nitric oxide, prostaglandin I2 and thromboxane A2
of vasoconstriction induced by an α-agonist in mesenteric arterial
bed from diabetic rats. Diabetologia. 41:1410–1418. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Beckman JS and Koppenol WH: Nitric oxide,
superoxide, and peroxynitrite: the good, the bad, and the ugly. Am
J Physiol. 40:C14241996.
|
|
17
|
Alderton WK, Cooper CE and Knowles RG:
Nitric oxide synthases: structure, function and inhibition. Biochem
J. 357:593–615. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hollenberg SM and Cinel I:
Bench-to-bedside review: nitric oxide in critical illness-update
2008. Crit Care. 13:2182009. View
Article : Google Scholar
|
|
19
|
Esper RJ, Nordaby RA, Vilariño JO,
Paragano A, Cacharrón JL and Machado RA: Endothelial dysfunction: a
comprehensive appraisal. Cardiovasc Diabetol. 5:4–22. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mudau M, Genis A, Lochner A and Strijdom
H: Endothelial dysfunction: the early predictor of atherosclerosis.
Cardiovasc J Afr. 23:222–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Frank PG, Pavlides S and Lisanti MP:
Caveolae and transcytosis in endothelial cells: role in
atherosclerosis. Cell Tissue Res. 335:41–47. 2009. View Article : Google Scholar
|
|
22
|
Sowa G: Caveolae, caveolins, cavins, and
endothelial cell function: new insights. Front Physiol. 2:1202012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Widlansky ME, Gokce N, Keaney JF Jr and
Vita JA: The clinical implications of endothelial dysfunction. J Am
Coll Cardiol. 42:1149–1160. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim VN: MicroRNA biogenesis: coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun X, Belkin N and Feinberg MW:
Endothelial microRNAs and atherosclerosis. Curr Atheroscler Rep.
15:1–13. 2013. View Article : Google Scholar
|
|
26
|
Loyer X, Potteaux S, Vion AC, et al:
Inhibition of MicroRNA-92a Prevents Endothelial Dysfunction and
Atherosclerosis in Mice. Circ Res. 114:434–443. 2014. View Article : Google Scholar
|
|
27
|
Menghini R, Casagrande V and Federici M:
MicroRNAs in endothelial senescence and atherosclerosis. J
Cardiovasc Transl Res. 6:924–930. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X, Shao S, Geng H, et al: Expression
profiles of six circulating microRNAs critical to atherosclerosis
in patients with subclinical hypothyroidism: a clinical study. J
Clin Endocrinol Metab. 99:E766–774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Turemen EE, Cetinarslan B, Sahin T,
Canturk Z and Tarkun I: Endothelial dysfunction and low grade
chronic inflammation in subclinical hypothyroidism due to
autoimmune thyroiditis. Endocr J. 58:349–354. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dardano A, Ghiadoni L, Plantinga Y, et al:
Recombinant human thyrotropin reduces endothelium-dependent
vasodilation in patients monitored for differentiated thyroid
carcinoma. J Clin Endocrinol Metab. 91:4175–4178. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao N, Zhang W, Zhang YZ, Yang Q and Chen
SH: Carotid intima-media thickness in patients with subclinical
hypothyroidism: a meta-analysis. Atherosclerosis. 227:18–25. 2013.
View Article : Google Scholar
|
|
32
|
Balzan S, Del Carratore R, Nicolini G, et
al: Proangiogenic effect of TSH in human microvascular endothelial
cells through its membrane receptor. J Clin Endocrinol Metab.
97:1763–1770. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tian L, Zhang L, Liu J, Guo T, Gao C and
Ni J: Effects of TSH on the function of human umbilical vein
endothelial cells. J Mol Endocrinol. 52:215–222. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Zhong J, Wei W, et al:
Developmental iodine deficiency and hypothyroidism impair neural
development, upregulate caveolin-1, and downregulate
synaptotagmin-1 in the rat cerebellum. Biol Trace Elem Res.
144:1039–1049. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gong J, Dong J, Wang Y, et al:
Developmental iodine deficiency and hypothyroidism impair neural
development, up-regulate caveolin-1 and down-regulate synaptophysin
in rat hippocampus. J Neuroendocrinology. 22:129–139. 2010.
View Article : Google Scholar
|
|
36
|
Sarati LI, Martinez CR, Artés N, et al:
Hypothyroidism: age-related influence on cardiovascular nitric
oxide system in rats. Metabolism. 61:1301–1311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Latif R, Ando T and Davies TF: Lipid rafts
are triage centers for multimeric and monomeric thyrotropin
receptor regulation. Endocrinology. 148:3164–3175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ito A, Tsao PS, Adimoolam S, Kimoto M,
Ogawa T and Cooke JP: Novel mechanism for endothelial dysfunction:
dysregulation of dimethylarginine dimethylaminohydrolase.
Circulation. 99:3092–3095. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nofer J-R, van der Giet M, Tölle M, et al:
HDL induces NO-dependent vasorelaxation via the lysophospholipid
receptor S1P3. J Clin Invest. 113:569–581. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lai Y, Wang J, Jiang F, et al: The
relationship between serum thyrotropin and components of metabolic
syndrome. Endocr J. 58:23–30. 2011. View Article : Google Scholar
|
|
41
|
Åsvold BO, Vatten LJ, Nilsen TI and Bjøro
T: The association between TSH within the reference range and serum
lipid concentrations in a population-based study. The HUNT Study.
Eur J Endocrinol. 156:181–186. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Geng H, Zhang X, Wang C, et al: Even
mildly elevated TSH is associated with an atherogenic lipid profile
in postmenopausal women with subclinical hypothyroidism. Endocr
Res. Mar 28–2014.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xiang GD, Xiang LW, He HL and Zhao LS:
Postprandial lipaemia suppresses endothelium-dependent arterial
dilation in patients with hypothyroidism. Endocrine. 42:391–398.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tian L, Song Y, Xing M, et al: A novel
role for thyroid-stimulating hormone: Up-regulation of hepatic
3-hydroxy-3-methyl-glutaryl-coenzyme a reductase expression through
the cyclic adenosine monophosphate/protein kinase A/cyclic
adenosine monophosphate-responsive element binding protein pathway.
Hepatology. 52:1401–1409. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Taddei S, Caraccio N, Virdis A, et al:
Low-grade systemic inflammation causes endothelial dysfunction in
patients with Hashimoto’s thyroiditis. J Clin Endocrinol Metab.
91:5076–5082. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ridker PM, Rifai N, Stampfer MJ and
Hennekens CH: Plasma concentration of interleukin-6 and the risk of
future myocardial infarction among apparently healthy men.
Circulation. 101:1767–1772. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Antunes TT, Gagnon A, Bell A and Sorisky
A: Thyroid-stimulating hormone stimulates interleukin-6 release
from 3T3-L1 adipocytes through a cAMP-protein kinase A pathway.
Obes Res. 13:2066–2071. 2005. View Article : Google Scholar
|
|
48
|
Zhang C, Xu X, Potter BJ, et al: TNF-alpha
contributes to endothelial dysfunction in ischemia/reperfusion
injury. Arterioscler Thromb Vasc Biol. 26:475–480. 2006. View Article : Google Scholar
|
|
49
|
Whetsell M, Bagriacik EU, Seetharamaiah
GS, Prabhakar BS and Klein JR: Neuroendocrine-induced synthesis of
bone marrow-derived cytokines with inflammatory immunomodulating
properties. Cell Immunol. 192:159–166. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Christ-Crain M, Meier C, Guglielmetti M,
et al: Elevated C-reactive protein and homocysteine values:
cardiovascular risk factors in hypothyroidism? A cross-sectional
and a double-blind, placebo-controlled trial. Atherosclerosis.
166:379–386. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kvetny J, Heldgaard PE, Bladbjerg EM and
Gram J: Subclinical hypothyroidism is associated with a low-grade
inflammation, increased triglyceride levels and predicts
cardiovascular disease in males below 50 years. Clin Endocrinol
(Oxf). 61:232–238. 2004. View Article : Google Scholar
|
|
52
|
Tuzcu A, Bahceci M, Gokalp D, Tuzun Y and
Gunes K: Subclinical hypothyroidism may be associated with elevated
high-sensitive c-reactive protein (low grade inflammation) and
fasting hyperinsulinemia. Endocr J. 52:89–94. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Verma S, Li S-H, Badiwala MV, et al:
Endothelin antagonism and interleukin-6 inhibition attenuate the
proatherogenic effects of C-reactive protein. Circulation.
105:1890–1896. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Cai H and Harrison DG: Endothelial
dysfunction in cardiovascular diseases: the role of oxidant stress.
Circ Res. 87:840–844. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lubos E, Handy DE and Loscalzo J: Role of
oxidative stress and nitric oxide in atherothrombosis. Front
Biosci. 13:5323–5344. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
56
|
Higashi Y, Noma K, Yoshizumi M and Kihara
Y: Endothelial function and oxidative stress in cardiovascular
diseases. Circ J. 73:411–418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Coria MJ, Pastran AI and Gimenez MS: Serum
oxidative stress parameters of women with hypothyroidism. Acta
Biomed. 80:135–139. 2009.PubMed/NCBI
|
|
58
|
Torun AN, Kulaksizoglu S, Kulaksizoglu M,
Pamuk BO, Isbilen E and Tutuncu NB: Serum total antioxidant status
and lipid peroxidation marker malondialdehyde levels in overt and
subclinical hypothyroidism. Clin Endocrinol (Oxf). 70:469–474.
2009. View Article : Google Scholar
|
|
59
|
Cebeci E, Alibaz-Oner F, Usta M, Yurdakul
S and Erguney M: Evaluation of oxidative stress, the activities of
paraoxonase and arylesterase in patients with subclinical
hypothyroidism. J Investig Med. 60:23–28. 2012.
|
|
60
|
Ozturk U, Vural P, Ozderya A, Karadag B,
Dogru-Abbasoglu S and Uysal M: Oxidative stress parameters in serum
and low density lipoproteins of Hashimoto’s thyroiditis patients
with subclinical and overt hypothyroidism. Int Immunopharmacol.
14:349–352. 2012. View Article : Google Scholar
|
|
61
|
GDX, JHP, HLS and LSZ: Alpha-lipoic acid
improves endothelial dysfunction in patients with subclinical
hypothyroidism. Exp Clin Endocrinol Diabetes. 118:625–629. 2010.
View Article : Google Scholar
|
|
62
|
Fujii N, Tsuchihashi K, Sasao H, et al:
Insulin resistance functionally limits endothelium-dependent
coronary vasodilation in nondiabetic patients. Heart Vessels.
23:9–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kim J-a, Montagnani M, Koh KK and Quon MJ:
Reciprocal relationships between insulin resistance and endothelial
dysfunction molecular and pathophysiological mechanisms.
Circulation. 113:1888–1904. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Gen R, Akbay E and Sezer K: Insulin
resistance and cardiovascular risk factors in patients with mild
and severe subclinical hypothyroidism. The Endocrinologist.
20:128–130. 2010. View Article : Google Scholar
|
|
65
|
Maratou E, Hadjidakis DJ, Kollias A, et
al: Studies of insulin resistance in patients with clinical and
subclinical hypothyroidism. Eur J Endocrinol. 160:785–790. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Al Sayed A, Al Ali N and Alfadhli E:
Subclinical hypothyroidism is associated with early insulin
resistance in Kuwaiti women. Endocr J. 53:653–657. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Peeters RP, Van Der Deure WM, Van Den Beld
AW, et al: The Asp727Glu polymorphism in the TSH receptor is
associated with insulin resistance in healthy elderly men. Clin
Endocrinol (Oxf). 66:808–815. 2007. View Article : Google Scholar
|
|
68
|
Taddei S, Caraccio N, Virdis A, et al:
Impaired endothelium-dependent vasodilatation in subclinical
hypothyroidism: beneficial effect of levothyroxine therapy. J Clin
Endocrinol Metab. 88:3731–3737. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Monzani F, Caraccio N, Kozakowa M, et al:
Effect of levothyroxine replacement on lipid profile and
intima-media thickness in subclinical hypothyroidism: a
double-blind, placebo-controlled study. J Clin Endocrinol Metab.
89:2099–2106. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Oner FA, Yurdakul S, Oner E, Uzum AK and
Erguney M: Evaluation of the effect of L-thyroxin therapy on
endothelial functions in patients with subclinical hypothyroidism.
Endocrine. 40:280–284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Razvi S, Ingoe L, Keeka G, Oates C,
McMillan C and Weaver JU: The beneficial effect of L-thyroxine on
cardiovascular risk factors, endothelial function, and quality of
life in subclinical hypothyroidism: randomized, crossover trial. J
Clin Endocrinol Metab. 92:1715–1723. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Adrees M, Gibney J, El-Saeity N and Boran
G: Effects of 18 months of l-T4 replacement in women with
subclinical hypothyroidism. Clin Endocrinol (Oxf). 71:298–303.
2009. View Article : Google Scholar
|
|
73
|
Cabral MD, Teixeira P, Soares D, Leite S,
Salles E and Waisman M: Effects of thyroxine replacement on
endothelial function and carotid artery intima-media thickness in
female patients with mild subclinical hypothyroidism. Clinics (Sao
Paulo). 66:1321–1328. 2011.
|
|
74
|
Pasqualetti G, Tognini S, Polini A,
Caraccio N and Monzani F: Is subclinical hypothyroidism a
cardiovascular risk factor in the elderly? J Clin Endocrinol Metab.
98:2256–2266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Razvi S, Weaver JU, Butler TJ and Pearce
SH: Levothyroxine treatment of subclinical hypothyroidism, fatal
and nonfatal cardiovascular events, and mortality. Arch Intern Med.
178:811–817. 2012.
|
|
76
|
Cooper DS: Clinical practice. Subclinical
hypothyroidism. N Engl J Med. 345:260–265. 2001. View Article : Google Scholar : PubMed/NCBI
|
